Syndax
Syndax is a Massachusetts-based biopharmaceutical company that researches and develops novel therapies for the treatment of cancer.
Business Model:
Revenue: $126.6M
Employees: 51-200
Industries / Tags:
Detailed Syndax Information
Geographic Data
Address: 35 Gatehouse Drive
City: Waltham
State: MA
Zip: 02451
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$75M
Raised Total:$274M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Syndax is a Massachusetts-based biopharmaceutical company that researches and develops novel therapies for the treatment of cancer.
Contact Phone:
+17814191400
Contact Email:
Syndax went public on 12/9/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
12/9/2020
Ticker Symbol:
SNDX
IPO Price:
$23/share
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
